PSA Test Reduces Advanced Prostate Cancers, University of Rochester Medical Center Study

The number of men with advanced prostate cancer at the time of first diagnosis would most likely rise without routine PSA screening, according to a new study. Without routine screening for prostate cancer with the prostate-specific antigen (PSA) test, 17,000 more men in the US every year would discover they had the advanced or metastatic form of the disease, according to a new study by the University of Rochester Medical Center (URMC) that is due to be published in the journal Cancer this week.